0000899243-20-032261.txt : 20201127 0000899243-20-032261.hdr.sgml : 20201127 20201127160849 ACCESSION NUMBER: 0000899243-20-032261 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201124 FILED AS OF DATE: 20201127 DATE AS OF CHANGE: 20201127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hunt Hazel CENTRAL INDEX KEY: 0001698307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 201355394 MAIL ADDRESS: STREET 1: C/O CORCEPT THERAPEUTICS INCORPORATED STREET 2: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-24 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001698307 Hunt Hazel C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 0 1 0 0 Chief Scientific Officer Common Stock 2020-11-24 4 M 0 50000 3.96 A 50200 D Common Stock 2020-11-24 4 F 0 31225 22.88 D 18975 D Stock Option (Right to Buy) 3.96 2020-11-24 4 M 0 50000 0.00 D 2021-01-03 Common Stock 50000 0 D The shares were withheld at the election of the Reporting Person as payment for the purchased shares and to satisfy tax withholding obligations in connection with the purchase of the shares. Fully exercisable. /s/ G. Charles Robb, Attorney-in-Fact for Hazel Hunt 2020-11-27